Market Place
Sourcing Support
Novo offers cheaper Wegovy for all cash-paying patients
25 Mar 2025 //
FIERCE PHARMA
Brazil`s Hypera to launch an Ozempic generic in 2026
22 Mar 2025 //
REUTERS
PatchMD Launches GLP-1 Support Patches For Weight Loss Patients
12 Mar 2025 //
GLOBENEWSWIRE
FDA to hold off action on weight-loss drug copies pending court ruling
11 Mar 2025 //
REUTERS
Novo trial with next-gen diabetes drug shows 15.7% weight loss
10 Mar 2025 //
REUTERS
Novo to sell Wegovy for $499 a month to cash-paying US customers
06 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Launches "My Ozempic Era" Campaign For Patients
03 Mar 2025 //
PR NEWSWIRE
Lilly offers weight-loss drugs in vials at a discount
27 Feb 2025 //
PRESS RELEASE
Novo`s Wegovy and Ozempic removed from US FDA shortage list
22 Feb 2025 //
REUTERS
FDA Confirms Wegovy & Ozempic Shortage Over, Novo Meets Demand
21 Feb 2025 //
PR NEWSWIRE
Rani Therapeutics Announces Preclinical Data on Semaglutide
05 Feb 2025 //
GLOBENEWSWIRE
Wegovy maker Novo says surging growth driving emissions higher
05 Feb 2025 //
REUTERS
FDA approves Novo`s Ozempic to cut risk of diabetic kidney disease
29 Jan 2025 //
PRESS RELEASE
Veru`s drug helps older obese patients on Wegovy preserve muscle
28 Jan 2025 //
REUTERS
Study of Novo, Lilly weight loss drugs show decrease in Alzheimer`s
22 Jan 2025 //
FIERCE PHARMA
Novo touts weight loss results in high-dose Wegovy study
18 Jan 2025 //
FIERCE PHARMA
Novo`s Ozempic, Wegovy picked for US Medicare price negotiations
18 Jan 2025 //
REUTERS
Novo Nordisk: Semaglutide Shows 20.7% Weight Loss In Step up Trial
17 Jan 2025 //
GLOBENEWSWIRE
Wegovy and Zepbound tipped to fuel $20B heart failure boom
08 Jan 2025 //
FIERCE PHARMA
Found Offers Affordable Needle-Free Semaglutide For Weight Care
08 Jan 2025 //
BUSINESSWIRE
SomaScan Assay Drives Insights On Semaglutide Published In Nature
08 Jan 2025 //
GLOBENEWSWIRE
Biomea Reports Preclinical Data On Icovamenib-Semaglutide Study
07 Jan 2025 //
GLOBENEWSWIRE
Eden Unveils the World`s First Compounded GLP-1 Rx Gummy
31 Dec 2024 //
PR NEWSWIRE
Novo stock crashes after CagriSema misses weight-loss goal
21 Dec 2024 //
FIERCE BIOTECH
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Ad Engagement
19 Dec 2024 //
BUSINESSWIRE
TNF Pharma Launches Trial on Lead Candidate in Sarcopenia/Frailty
19 Dec 2024 //
BUSINESSWIRE
Ascletis Announces ASC47 for Obesity with Superior Weight Loss
18 Dec 2024 //
PR NEWSWIRE
Novo Nordisk`s Ozempic faces EU review for potential eye disease connection
18 Dec 2024 //
REUTERS
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Novo`s Ozempic faces scrutiny over potential link to rare eye disease
17 Dec 2024 //
REUTERS
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
14 Dec 2024 //
BIOSPACE
Cellev8 Nutrition Launches First GLP1 Support Gummy
12 Dec 2024 //
ACCESSWIRE
PeptiDream Shows Oral Myostatin Inhibitors Prevent Lean Mass Loss
12 Dec 2024 //
BUSINESSWIRE
FDA chief Defends Obesity Work Before Senate RFK Jr Criticism
06 Dec 2024 //
REUTERS
Lilly`s Zepbound Beats Wegovy In Weight Loss Trial: 20.2% Vs. 13.7%
05 Dec 2024 //
PR NEWSWIRE
Novo India execs urge early Wegovy launch as weight-loss rival
03 Dec 2024 //
ECONOMICTIMES
BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide
02 Dec 2024 //
ACCESSWIRE
ProLynx Publishes Once Monthly Semaglutide in PNAS
02 Dec 2024 //
PR NEWSWIRE
Novo Nordisk launches obesity drug Wegovy in China
19 Nov 2024 //
REUTERS
Helix Introduces Precision Model for Semaglutide Weight Loss
13 Nov 2024 //
PR NEWSWIRE
US Minority Veterans Face Unequal Access to Ozempic, Wegovy
11 Nov 2024 //
REUTERS
Novo expects high demand for its obesity drugs in India
07 Nov 2024 //
REUTERS
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
06 Nov 2024 //
FIERCE PHARMA
Novo affirms 25% weight-loss for experimental drug CagriSema
06 Nov 2024 //
REUTERS
Novo`s Wegovy weight-loss drug sales beat forecast, shares jump
06 Nov 2024 //
REUTERS
Select Trial: Semaglutide Reduces Hospital Admissions in Obesity
03 Nov 2024 //
PR NEWSWIRE
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
01 Nov 2024 //
FIERCE PHARMA
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
Tiziana Life Sciences Announces Ozempic & Anti-CD3 Study Results
30 Oct 2024 //
GLOBENEWSWIRE
STEP 9 Study: Semaglutide Reduces OA Pain in Obesity Patients
30 Oct 2024 //
PR NEWSWIRE
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Study
25 Oct 2024 //
BIOSPACE
Novo asks US to stop compounding weight-loss drug copies
24 Oct 2024 //
REUTERS
Novo oral diabetes drug cuts heart-related risks by 14% in study
22 Oct 2024 //
REUTERS
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
15 Oct 2024 //
FIERCE BIOTECH
Wegovy maker Novo bets big on talent, AI partnerships in India
11 Oct 2024 //
ECONOMICTIMES
WeightWatchers to offer compounded version of Novo`s weight-loss drug
08 Oct 2024 //
REUTERS
Novo settles with Mylan over potential Ozempic generic
07 Oct 2024 //
FIERCE PHARMA
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
26 Sep 2024 //
FIERCE PHARMA
US Senator Sanders says middlemen won`t punish Novo
25 Sep 2024 //
REUTERS
